X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5659) 5659
Newsletter (952) 952
Publication (664) 664
Book Review (650) 650
Newspaper Article (334) 334
Government Document (67) 67
Magazine Article (35) 35
Conference Proceeding (17) 17
Book Chapter (14) 14
Trade Publication Article (14) 14
Transcript (8) 8
Dissertation (7) 7
Web Resource (5) 5
Book / eBook (4) 4
Reference (4) 4
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
buprenorphine (5352) 5352
index medicus (4378) 4378
humans (3372) 3372
male (2528) 2528
female (2318) 2318
adult (1702) 1702
buprenorphine - administration & dosage (1666) 1666
substance abuse (1620) 1620
methadone (1383) 1383
buprenorphine - therapeutic use (1350) 1350
animals (1145) 1145
psychiatry (1108) 1108
middle aged (1101) 1101
opioids (1059) 1059
care and treatment (995) 995
drug abuse (903) 903
narcotics (874) 874
pharmacology & pharmacy (856) 856
opioid-related disorders - drug therapy (845) 845
analgesics, opioid - administration & dosage (841) 841
morphine (801) 801
drug use (772) 772
pain (753) 753
substance abuse treatment (739) 739
dosage and administration (720) 720
heroin (672) 672
analysis (652) 652
drugs (636) 636
treatment outcome (613) 613
narcotic antagonists - therapeutic use (608) 608
buprenorphine - adverse effects (605) 605
buprenorphine - pharmacology (585) 585
research (581) 581
opioid dependence (574) 574
analgesics, opioid - therapeutic use (573) 573
dependency (572) 572
addiction (571) 571
naloxone (565) 565
dose-response relationship, drug (562) 562
rats (539) 539
article (537) 537
methadone - therapeutic use (517) 517
veterinary sciences (517) 517
drug therapy (499) 499
opioid-related disorders - rehabilitation (496) 496
analgesia (467) 467
dependence (462) 462
pharmacotherapy (460) 460
aged (446) 446
analgesics, opioid - adverse effects (445) 445
usa (421) 421
narcotic antagonists - administration & dosage (417) 417
young adult (391) 391
abuse (384) 384
pregnancy (383) 383
maintenance (381) 381
analgesics (368) 368
naltrexone (362) 362
double-blind method (361) 361
neurosciences (360) 360
psychology, clinical (358) 358
methadone - administration & dosage (357) 357
adolescent (353) 353
treatment (352) 352
pharmacology (351) 351
usage (346) 346
medicine, general & internal (334) 334
time factors (330) 330
abridged index medicus (327) 327
pain - drug therapy (327) 327
opiate substitution treatment - methods (321) 321
analgesics, opioid - pharmacology (308) 308
pharmacokinetics (306) 306
cocaine (305) 305
methadone-maintenance (305) 305
clinical trials (303) 303
health aspects (297) 297
management (293) 293
detoxification (288) 288
united-states (287) 287
patients (276) 276
medical research (271) 271
united states (265) 265
pain, postoperative - drug therapy (263) 263
chronic pain (262) 262
drug addiction (261) 261
methadone hydrochloride (261) 261
anesthesiology (259) 259
mice (255) 255
physicians (254) 254
risk factors (251) 251
complications and side effects (248) 248
opiate substitution treatment (246) 246
fentanyl (244) 244
buprenorphine - pharmacokinetics (243) 243
pain management (240) 240
opioid-related disorders - epidemiology (237) 237
drug administration schedule (234) 234
opioid (232) 232
anesthesia (229) 229
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6693) 6693
French (100) 100
Japanese (89) 89
German (72) 72
Italian (31) 31
Spanish (26) 26
Norwegian (16) 16
Danish (15) 15
Russian (10) 10
Swedish (10) 10
Portuguese (8) 8
Chinese (4) 4
Korean (3) 3
Croatian (2) 2
Polish (2) 2
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Latvian (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Pharmacology, ISSN 0007-1188, 07/2009, Volume 157, Issue 5, pp. 831 - 843
Background and purpose:  Buprenorphine displays attributes of opioids, but also some features distinct from them. We examined spinal and supraspinal signal... 
mechanism of action | supraspinal | buprenorphine | analgesia (antinociception) | Supraspinal | Analgesia (antinociception) | Buprenorphine | Mechanism of action | MOLECULAR REARRANGEMENTS | OKADAIC-ACID | ANTISENSE OLIGODEOXYNUCLEOTIDES | MU-OPIOID RECEPTOR | INTRINSIC EFFICACY | SERINE/THREONINE PROTEIN PHOSPHATASES | PARTIAL AGONIST | PHARMACOLOGY & PHARMACY | MORPHINE-THEBAINE GROUP | TAIL-FLICK TEST | INDUCED ANTINOCICEPTION | Fentanyl - administration & dosage | Piperazines - administration & dosage | Narcotic Antagonists - administration & dosage | Serotonin Antagonists - administration & dosage | Phosphoprotein Phosphatases - metabolism | Aminoquinolines - administration & dosage | Injections, Intraventricular | Oligonucleotides, Antisense - metabolism | Male | Opioid Peptides - administration & dosage | Pain - chemically induced | Adrenergic alpha-Antagonists - administration & dosage | Pain - metabolism | GTP-Binding Proteins - genetics | Okadaic Acid - administration & dosage | Brain - metabolism | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Benzamides - administration & dosage | Pain Threshold - drug effects | Anesthetics, Local - administration & dosage | Pertussis Toxin - administration & dosage | Receptor, Serotonin, 5-HT1A - metabolism | Disease Models, Animal | Receptors, Opioid - metabolism | Injections, Spinal | Pyridines - administration & dosage | Pain - prevention & control | Phosphoprotein Phosphatases - antagonists & inhibitors | Yohimbine - administration & dosage | Brain - drug effects | Buprenorphine - administration & dosage | Animals | Signal Transduction - drug effects | Analgesics, Opioid - administration & dosage | Acetylcholine | Mice | Naloxone - administration & dosage | Pain Measurement | Morphine - administration & dosage | Receptors, Opioid - drug effects | Serotonin 5-HT1 Receptor Antagonists | GTP-Binding Proteins - metabolism | Index Medicus | Research Papers
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2015, Volume 63, Issue 2, pp. 364 - 369
Journal Article
Addiction, ISSN 0965-2140, 03/2011, Volume 106, Issue 3, pp. 574 - 580
Aims  More than half of infants exposed to opioids in utero develop neonatal abstinence syndrome (NAS) of severity to require pharmacological therapy. Current... 
Buprenorphine | neonatal abstinence syndrome | morphine | pediatric | sublingual drug administration | Morphine | Sublingual drug administration | Pediatric | Neonatal abstinence syndrome | CONTROLLED-TRIAL | MANAGEMENT | PSYCHIATRY | SUBSTANCE ABUSE | OPIATE WITHDRAWAL | NEWBORNS | CARE | TERM INFANTS | DRUG-WITHDRAWAL | NATIONAL-SURVEY | METHADONE-MAINTENANCE | Severity of Illness Index | Narcotic Antagonists - administration & dosage | Administration, Sublingual | Humans | Hypnotics and Sedatives - administration & dosage | Narcotic Antagonists - adverse effects | Male | Treatment Outcome | Dose-Response Relationship, Drug | Pregnancy | Birth Weight | Buprenorphine - administration & dosage | Phenobarbital - administration & dosage | Buprenorphine - adverse effects | Cytomegalovirus Infections - etiology | Opiate Substitution Treatment - methods | Adult | Female | Neonatal Abstinence Syndrome - drug therapy | Morphine - administration & dosage | Infant, Newborn | Length of Stay - statistics & numerical data | Morphine - adverse effects | Infants (Newborn) | Medical colleges | Care and treatment | Safety regulations | Children's hospitals | Dosage and administration | Clinical trials | Substance abuse treatment | Neonatal care | Narcotics | Drug therapy | Indexing in process | Index Medicus | buprenorphine (D002047) | pediatric (D010372) | Neonatal Abstinence Syndrome (D009357) | morphine (D009020) | Sublingual Drug Administration (D000286)
Journal Article
AJN, American Journal of Nursing, ISSN 0002-936X, 04/2018, Volume 118, Issue 4, pp. 23 - 23
Information on the new route for Buprenorphine administration is discussed. Buprenorphine, used to treat opioid use disorder, is now available in a... 
NURSING | Medical personnel | Drug abuse | Buprenorphine | Nurses | Drug administration
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2012, Volume 54, Issue 3, pp. 414 - 423
Background. This study examined drug interactions between buprenorphine, a partial opioid agonist used for opioid dependence treatment and pain management, and... 
Statistical median | HIV/AIDS | HIV | Memory interference | Drug interactions | Medications | Methadone | Pharmacokinetics | Dosage | Data ranges | Opioid analgesics | INFECTIOUS DISEASES | GLUCURONIDATION | VALIDATION | MICROBIOLOGY | OPIOID DEPENDENCE | DARUNAVIR/RITONAVIR | OPIATE WITHDRAWAL | IMMUNOLOGY | DRUG-DRUG INTERACTION | NORBUPRENORPHINE | PHARMACOKINETICS | METHADONE | IN-VIVO | History, 17th Century | Narcotic Antagonists - administration & dosage | Darunavir | Area Under Curve | Buprenorphine - blood | Protease Inhibitors - pharmacokinetics | Humans | Half-Life | Buprenorphine - pharmacokinetics | Male | Carbamates - administration & dosage | Carbamates - pharmacokinetics | Anti-HIV Agents - administration & dosage | Sulfonamides - blood | Drug Interactions | Buprenorphine - analogs & derivatives | Protease Inhibitors - administration & dosage | Female | Opiate Substitution Treatment | Anti-HIV Agents - blood | Narcotic Antagonists - pharmacokinetics | Organophosphates - administration & dosage | Organophosphates - pharmacokinetics | Ritonavir - administration & dosage | Organophosphates - blood | Ritonavir - blood | History, 16th Century | Carbamates - blood | Sulfonamides - pharmacokinetics | Buprenorphine - administration & dosage | Ritonavir - pharmacokinetics | Naloxone - pharmacology | Anti-HIV Agents - pharmacokinetics | Protease Inhibitors - blood | Sulfonamides - administration & dosage | Usage | Fosamprenavir | Dosage and administration | Buprenorphine | Protease inhibitors | Substance abuse treatment | Metabolites | Human immunodeficiency virus--HIV | Pain management | Index Medicus | AIDS
Journal Article
Pain Practice, ISSN 1530-7085, 07/2008, Volume 8, Issue 4, pp. 287 - 313
Journal Article
Journal of Substance Abuse Treatment, ISSN 0740-5472, 2010, Volume 38, Issue 1, pp. S31 - S43
Journal Article